细胞治疗、基因治疗/基因编辑、核酸药物，最近火热的几个方向

安全性非常好No dose-limiting toxicities, and no cases of any grade of cytokine release syndrome, immune effector cell-associated neurotoxicity syndrome, or graft-versus-host disease, were observed. No FT596-related serious adverse events (SAEs) were reported, and the only Grade ≥3 adverse events deemed possibly related to FT596 were neutrophil count decreased, white blood cell count decreased, and lymphocyte count decreased. 网页链接

网页链接 

网页链接 (CD19, No reported CRS, GvHD or neurotoxicity,7 / 11 CRs, 4线)